Elevance falls as Medicare regulators plan to halt new enrollments

Shares of health insurer Elevance Health ELV.N fall 3% to $310 premarket

 Co says the Centers for Medicare & Medicaid Services (CMS) plans to halt new Medicare Advantage‑Prescription Drug enrollments from March 31 over concerns tied to how it submitted risk‑adjustment data before April 2023

ELV says current members will not see changes to coverage and that it revised its practices last April; adds it is working with CMS but timing and outcome remain uncertain

Shares fell 5% in 2025